{"transactions":[{"id":4625901,"issuer":{"id":9400,"kind":"organization","name":"newcleo plc","symbol":"NWCL"},"owners":[{"id":149020,"kind":"person","name":"Buono Stefano","position":1,"cik":"0001665113","reported_name":"Buono Stefano","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Shares","published_at":"2026-09-24T01:12:58.000Z","date":"2026-09-21","kind":"grant","planned":false,"acquired":true,"shares":1921029,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Elysia Capital I SCSp"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof."},{"field":"shares","element":"transactionShares","label":"F5","text":"Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof."}],"balance_after":1921029,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1921029},"source":{"system":"sec-edgar","filing":"0000950103-26-014418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2131813/000095010326014418/ownership.xml","form_type":"4"}},{"id":4625900,"issuer":{"id":9400,"kind":"organization","name":"newcleo plc","symbol":"NWCL"},"owners":[{"id":149020,"kind":"person","name":"Buono Stefano","position":1,"cik":"0001665113","reported_name":"Buono Stefano","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Shares","published_at":"2026-09-24T01:12:58.000Z","date":"2026-09-21","kind":"grant","planned":false,"acquired":true,"shares":11960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof."},{"field":"shares","element":"transactionShares","label":"F5","text":"Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Reflects the issuance of Class B Shares in accordance with the BCA. The Class B Shares will automatically convert and be re-designated into the same number of Ordinary shares, on a one-for-one basis, as follows: (i) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% in the event the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading days within a 30 trading day period, provided that such price attainment occurs during the period beginning on September 21, 2026 and ending on the five-year anniversary thereof."}],"balance_after":11960,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11960},"source":{"system":"sec-edgar","filing":"0000950103-26-014418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2131813/000095010326014418/ownership.xml","form_type":"4"}},{"id":4625899,"issuer":{"id":9400,"kind":"organization","name":"newcleo plc","symbol":"NWCL"},"owners":[{"id":149020,"kind":"person","name":"Buono Stefano","position":1,"cik":"0001665113","reported_name":"Buono Stefano","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-09-24T01:12:58.000Z","date":"2026-09-21","kind":"grant","planned":false,"acquired":true,"shares":9814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of \"Company Earnout Bonus Options\" to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the \"BCA\"). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of \"Company Earnout Bonus Options\" to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the \"BCA\"). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions."},{"field":"shares","element":"transactionShares","label":"F4","text":"These stock options vest as to service on each of the first four anniversaries of September 1, 2022, subject to continued employment on each vesting date and applicable accelerated vesting provisions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of \"Company Earnout Bonus Options\" to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the \"BCA\"). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options vest as to service on each of the first four anniversaries of September 1, 2022, subject to continued employment on each vesting date and applicable accelerated vesting provisions."}],"balance_after":9814,"derivative":{"exercise_price":0.0228,"expiration_date":"2032-08-31","underlying":"Ordinary Shares","underlying_shares":9814},"source":{"system":"sec-edgar","filing":"0000950103-26-014418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2131813/000095010326014418/ownership.xml","form_type":"4"}},{"id":4625898,"issuer":{"id":9400,"kind":"organization","name":"newcleo plc","symbol":"NWCL"},"owners":[{"id":149020,"kind":"person","name":"Buono Stefano","position":1,"cik":"0001665113","reported_name":"Buono Stefano","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-09-24T01:12:58.000Z","date":"2026-09-21","kind":"grant","planned":false,"acquired":true,"shares":4291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of \"Company Earnout Bonus Options\" to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the \"BCA\"). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of \"Company Earnout Bonus Options\" to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the \"BCA\"). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions."},{"field":"shares","element":"transactionShares","label":"F3","text":"These stock options vest as to service on each of the first four anniversaries of September 1, 2023, subject to continued employment on each vesting date and applicable accelerated vesting provisions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of \"Company Earnout Bonus Options\" to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the \"BCA\"). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest as to service on each of the first four anniversaries of September 1, 2023, subject to continued employment on each vesting date and applicable accelerated vesting provisions."}],"balance_after":4291,"derivative":{"exercise_price":0.0228,"expiration_date":"2033-08-31","underlying":"Ordinary Shares","underlying_shares":4291},"source":{"system":"sec-edgar","filing":"0000950103-26-014418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2131813/000095010326014418/ownership.xml","form_type":"4"}},{"id":4625897,"issuer":{"id":9400,"kind":"organization","name":"newcleo plc","symbol":"NWCL"},"owners":[{"id":149020,"kind":"person","name":"Buono Stefano","position":1,"cik":"0001665113","reported_name":"Buono Stefano","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-09-24T01:12:58.000Z","date":"2026-09-21","kind":"grant","planned":false,"acquired":true,"shares":134596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of \"Company Earnout Bonus Options\" to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the \"BCA\"). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of \"Company Earnout Bonus Options\" to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the \"BCA\"). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions."},{"field":"shares","element":"transactionShares","label":"F2","text":"These stock options vest as to service on each of the first four anniversaries of December 1, 2025, subject to continued employment on each vesting date and applicable accelerated vesting provisions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the grant of \"Company Earnout Bonus Options\" to purchase Ordinary Shares under the Business Combination Agreement, dated May 26, 2026, by and between Newhold Investment Corp III, Newcleo1 Ltd., Newcleo2 Ltd., and Newcleo Ltd. (the \"BCA\"). The Company Earnout Bonus Options vest and become exercisable as follows: (i) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $15.00 during any 20 trading days within a 30 trading day period and (ii) 50% if the volume-weighted average price per Ordinary Share equals or exceeds $18.00 during any trading day within a 30 trading day period, provided that (A) such price attainment occurs between September 21, 2026 and September 21, 2031 and (B) the Company Earnout Bonus Options satisfy applicable service vesting conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest as to service on each of the first four anniversaries of December 1, 2025, subject to continued employment on each vesting date and applicable accelerated vesting provisions."}],"balance_after":134596,"derivative":{"exercise_price":0.0228,"expiration_date":"2035-12-01","underlying":"Ordinary Shares","underlying_shares":134596},"source":{"system":"sec-edgar","filing":"0000950103-26-014418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2131813/000095010326014418/ownership.xml","form_type":"4"}},{"id":3138304,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":149020,"kind":"person","name":"Buono Stefano","position":1,"cik":"0001665113","reported_name":"Buono Stefano","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-22T22:05:29.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":21518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the stock options will vest on November 20, 2020."}],"balance_after":21518,"derivative":{"exercise_price":3.2,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":21518},"source":{"system":"sec-edgar","filing":"0001493152-20-009756","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220009756/ownership.xml","form_type":"4"}},{"id":3138303,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":149020,"kind":"person","name":"Buono Stefano","position":1,"cik":"0001665113","reported_name":"Buono Stefano","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T22:05:29.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":17969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on November 20, 2020."}],"balance_after":287969,"source":{"system":"sec-edgar","filing":"0001493152-20-009756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220009756/ownership.xml","form_type":"4"}},{"id":3329352,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":149020,"kind":"person","name":"Buono Stefano","position":1,"cik":"0001665113","reported_name":"Buono Stefano","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2019-12-31T22:17:03.000Z","date":"2019-12-24","kind":"purchase","acquired":true,"shares":200000,"price":2.5,"value":500000.0,"ownership":{"direct":true},"balance_after":270000,"source":{"system":"sec-edgar","filing":"0001493152-19-019948","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315219019948/ownership.xml","form_type":"4"}},{"id":3514319,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":149020,"kind":"person","name":"Buono Stefano","position":1,"cik":"0001665113","reported_name":"Buono Stefano","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-23T22:28:50.000Z","date":"2019-05-21","kind":"grant","acquired":true,"shares":19827,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19827,"derivative":{"exercise_price":7.42,"exercise_date":"2019-11-21","expiration_date":"2029-05-21","underlying":"Common stock","underlying_shares":19827},"source":{"system":"sec-edgar","filing":"0001144204-19-028030","document":"tv522356_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419028030/tv522356_4.xml","form_type":"4"}},{"id":3557167,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":149020,"kind":"person","name":"Buono Stefano","position":1,"cik":"0001665113","reported_name":"Buono Stefano","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2019-04-12T14:20:24.000Z","date":"2019-04-11","kind":"purchase","acquired":true,"shares":49020,"price":7.9147,"value":387978.594,"ownership":{"direct":true},"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001144204-19-019439","document":"tv518835_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419019439/tv518835_form4.xml","form_type":"4"}},{"id":3557166,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":149020,"kind":"person","name":"Buono Stefano","position":1,"cik":"0001665113","reported_name":"Buono Stefano","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2019-04-12T14:20:24.000Z","date":"2019-04-10","kind":"purchase","acquired":true,"shares":20980,"price":7.5439,"value":158271.022,"ownership":{"direct":true},"balance_after":20980,"source":{"system":"sec-edgar","filing":"0001144204-19-019439","document":"tv518835_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419019439/tv518835_form4.xml","form_type":"4"}},{"id":3921246,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":149020,"kind":"person","name":"Buono Stefano","position":1,"cik":"0001665113","reported_name":"Buono Stefano","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-05-23T23:32:35.000Z","date":"2018-05-22","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% accelerated vesting on change of control."}],"balance_after":30000,"derivative":{"exercise_price":16.02,"exercise_date":"2018-11-22","expiration_date":"2018-05-22","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000318306-18-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000031830618000006/primary_doc.xml","form_type":"4"}}]}